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The purpose of this Editorial is to present an update of the evidence on bisphenol A (BPA) in 
Orthodontics by critically reviewing the available evidence, which often shows variable validity and derives 
from in vitro, animal, simulated in vivo, and in vivo experimental configurations; clarify several 
misconceptions which are the results of false assumption in the design of studies or limitations of 
instrumental analyses; and suggest ways to minimize the exposure of operator, staff and patients to this 
molecule. The wording of the title implies that the therapeutic team including the clinician and chair-side 
staff should be given priority with regard to ensuring the implementation of means to shield them from 
being exposed to BPA. This is because the operatory personnel is exposed repeatedly and for long periods of 
time to materials and processes, which may result in BPA production compared with patients who 
participate only once in such scenarios.   
BPA is a chemical produced in large quantities for use primarily in the production of polycarbonate 
plastics and epoxy resins, which have many applications in modern material items including food and drink 
packaging. The primary source of exposure to BPA for most people is through the diet. Whereas air, dust, 
and water (including skin handling of materials, or during bathing and swimming) are other possible sources 
of exposure, BPA in food and beverages accounts for the majority of daily human exposure. BPA can migrate 
into food from food and beverage containers with internal epoxy resin coatings and from consumer 
products made of polycarbonate plastic such as baby bottles, tableware, food containers, and water 
bottles.1 Leaching of BPA into packages and food carriers depends more on the temperature of the liquid 
than the age of the container, i.e., more migration with higher temperatures. 
Over the past decade, the effects of BPA on a wide array of tissues, organs and systems has been 
established through in vitro and animal studies, as well as case analyses and observations in humans.2-4 
Therefore, what was initially considered as a topic of dispute among scientists, professional societies and the 
industry, has reached the status of an unequivocally defined thesis, with organizations, at national with 
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international legislative level issuing relevant statements.5-7 These highlight the fact that BPA at levels as low 
as parts per billion (ppb) are unconjugated, which means that they are not metabolized and thus are 
biologically active, and are detected in human blood and tissues.8-9 
 
BPA AS ENDOCRINE DISRUPTOR 
Xenoestrogenicity is a relatively recently described property of certain polymeric molecules such as BPA, 
to express biological effects similar to those induced by natural estrogens. The similar chemical structure of 
BPA to natural estrogen oestradiol 17b is the reason for this deviation of the hormonal homeostasis from the 
proper pathway.10 
The effects of Endocrine disrupting compounds (EDC) were identified in the early 1960’ when the nests 
of bald eagles, which consumed prey contaminated with pesticides were found to produced 3-4 times fewer 
eaglets than the corresponding numbers recorded in the 1930’s11 In spite of the early recognition of these 
effects, it took several decades to for a substantial body of literature reporting biologic effects associated 
with these compounds to be accumulated, demonstrating the cohort of phenomena accompanying the 
exposure of organisms to BPA, which include hormonal-related effects.12 
For a given exposure period and BPA quantity, the accumulation of BPA in the body may vary as a 
function of the developmental stage and the gender of the subject. Exposure of infants to the chemical, 
leads to higher BPA body levels relative to that during adulthood, because of the absence of enzymes 
capable of metabolizing BPA to its biologically-inert form.12 Also, a sexual dimorphism is implied by several 
studies, which have reported higher plasma BPA levels in male than female foetuses even after correcting 
for a positive correlation between body weight and BPA concentration.13 Most importantly, there is 
extensive evidence that outcomes may not become apparent until long after BPA exposure during 
development has occurred. The issue of a very long latency for effects in utero to be observed is referred to 
as the developmental origins of adult health and disease (DOHaD) hypothesis.14 These developmental effects 
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are irreversible and can occur due to low-dose exposure during brief sensitive periods in development, even 
though no BPA may be detected when the damage or disease is expressed. 
The reader would understand the often contradicting conclusions of studies by considering the objective 
difficulty in reaching a definitive agreement with regard to levels of BPA released and potential effects; this 
is due to the fact that the biologic action of BPA sets in at very low concentrations, within the range of the 
detection threshold of the majority of standard analytical techniques.15-16  Specifically, substances such as 
octaphenol, are capable of altering the uptake of dopamine by hypothalamic cells in animals, at levels as low 
as 10 ppt (part per trillion or pg/l).17 Therefore, even if a precise and reliable quantitative estimation of BPA is 
attained, there is still a large window of uncertainty on its potential estrogenicity.   
The basic differences between the study of common toxicants or other hazardous materials and BPA, 
relate to the fact that natural hormones like 17ß-oestradiol educe effects at concentrations far beneath the 
levels at which all hormone receptors become bound.18 This observation has given rise to a new perspective 
of toxicity. Once all receptors are occupied, further increase in natural hormone levels does not result in an 
increased response. Conventional testing of substances for toxicological impact assessment, involves 
exposure to levels many times higher than those requiring for complete receptor binding. Thus, the lack of 
response to excessively high concentrations of effectors may be misinterpreted as lack of effect. Along with 
that, the effects of BPA on tissues follow a non-monotonic curve pattern, which is characterized by intense 
reactivity at low levels and no response at very high ones, respectively.19 
 
BPA AND ORTHODONTIC POLYMERIC MATERIALS 
The broader dental composite polymer materials literature has indicated that a wide range of effects 
can be induced upon exposure of insufficiently polymerized material to the oral environment. In general, the 
degree of cure or Carbon double bond conversion of polymers may modulate the physical and mechanical 
properties of the material especially solubility and degradation.20 This has pivotal role in altering the 
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biological performance of the materials because a less densely formed network resulting from a decreased 
conversion of double bonds, is associated with residual monomer leaching and release of substances which 
are constituent components of the polymer such as amines, polymerization initiators and inhibitors, among 
others. Additives such as plasticizers which are used for altering the brittle nature of most polymers include 
the phthalates, aromatic esters suspected to mimic hormones.21  
In dental materials, BPA is used as a raw material for formulation of Bis-GMA and polycarbonate 
products and as a general rule, estrogenic action is confined to molecules with a double benzoic ring. The 
implication of BPA release from dental biomaterials was first reported in a study, which assessed salivary 
BPA levels in patients with dental sealants.22 It may be worth noting that a considerable dispute exists on the 
actual release of BPA from sealants, since BPA release from sealants has not been confirmed at a large 
scale.23-24  
Orthodontic polymers considered in this section include resin adhesives and glass-ionomer modified 
adhesives (but not glass-ionomer cements) used for bonding brackets and fixed retainers; plastic brackets 
elastomeric ligatures and chains; protective wire-sleeves; acrylic Hawley appliances; and themo-formed 
retainers. A critical point in considering the potential implication of these materials in BPA release, relates 
not only to their composition and manufacturing process but also on their application mode. For example 
the application of orthodontic adhesives as bonding materials involves a sandwich (between bracket and 
enamel) material configuration, allowing only the peripheral margins of the material to be exposed to the 
oral cavity; this is vastly different from the use of adhesives in lingual fixed retainer bonding. In the latter 
scenario, the material approaches a 2-dimenional structure, with a large surface-to-volume ratio, and 
therefore exposure of the entire surface of the material to the oral environment takes place. This includes 
masticatory stresses, temperature variations, pH fluctuation, enzymatic degradation and oral microbiota 
material challenges, for periods of time many times higher than the duration of a typical orthodontic 
treatment. It should be stressed that a BPA release assay may not constitute conclusive evidence in 
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determining the potential of a material to give rise to BPA formation because of the threshold of 
chromatographic analyses used.25 This might be a case that the amount released could go undetected by the 
instrumental analysis. 
As an empirical rule, the potential of BPA release is restricted to those materials, which contain BPA 
as a precursor during manufacturing process. Obviously any polymer without an aromatic ring in its structure 
is free of this concern and therefore acrylic retainers and other linear carbon chain polymers possess no 
known risk for BPA release.  The materials which in most cases are manufactured with the use of BPA are 
polycarbonate brackets and Bis-GMA, although recently traces of the molecule have were identified in 
thermo-formed aligners. Bis-GMA-based orthodontic adhesives were manufactured with a BPA as a 
precursor, however most manufacturers have reported that they have abandoned this process.  
Systematic reviews on the subject identified that the published studies are contradictory with 
respect to the qualitative and quantitative parameters of BPA release from adhesives and sealants, probably 
because of the varying methodologies that have been employed.26-27 Results of one investigation showed no 
indication of BPA, another study demonstrated that increase of the distance between the light cure tip and 
the adhesive introduced a decrease in the degree of conversion of the polymer, which led to a greater BPA 
release, whereas the release of BPA from an orthodontic adhesive used to bond lingual fixed retainers 
indicated measurable amounts of BPA that were identified for all groups, with the highest found in the 
immersion media of the thirty-day immersed group. 28-34 In general, the in vivo assessment of BPA release in 
biological liquids indicates a broad variance along with a rise immediately after bonding of brackets or lingual 
fixed retainers.  
On another class of orthodontic materials, namely the polycarbonate aesthetic brackets, it has been 
reported that during the synthesis of polycarbonates, non-reacting BPA probably remains inside the 
materials and is released when these are immersed in water or organic solvents resulting in a rate of BPA 
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release increased with time and temperature,35-36 although the issue has not been unequivocally determined 
with respect to the xenoestrogenicity of the appliances.37 
Lastly, there has been promising efforts for the development of orthodontic adhesives for use with 
lingual fixed retainers at first stage, based on monomers without a BPA-derivative or precursor during the 
synthesis, and with similar performance with respect to bond strength, degree of carbon double bond 
conversion, hardness, oxygen inhibition polymerization zone and physical properties such as viscosity, with a 
widely used product.38-40 
For aligners the evidence is contradictory since BPA’s implication in the use of these products has not 
been conclusive at the cell culture or analytical level, with views, namely their inert profile41 or BPA release42, 
being supported by studies with different methodological approaches. 
 
MANAGING EXPOSURE IN AN ORTHODONTIC SETUP 
The important point in addressing this issue is to present the evidence and its potential 
consequences within the context of everyday life. The materials in question from the body of the literature 
are Bis-GMA-based adhesives, which additionally are manufactured with BPA as precursor; most of those 
materials are now claimed to be BPA-free.  
Various applications such as bonding materials for fixed retainers, where the adhesive exposes a vast 
surface relative to its volume to intraoral environment, might constitute a BPA release case scenario only if 
the adhesive derived from the use of BPA.  Also, during the debonding stage where the resin adhesive must 
be ground with the use of rotary instruments, the particulate matter produced might also have estrogenic 
action;43 this is a hazardous situation for the care provider and team, who are exposed to aerosol44-45 and to 
a lesser degree for the patient, based on the fact that the orthodontist and staff may be exposed to this 
factor repeatedly, whereas the patient only once. Access to fresh air, use of surgical mask and glasses, and 
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surgical suction are strongly advised for this treatment stage, as is the removal of as much material as 
possible without the use of rotary instruments. 
The foregoing discussion excludes most materials from the category or potential BPA releasing 
polymers and leaves only polycarbonate aesthetic brackets as potential BPA source. Care should be taken 
not to confuse all plastic aesthetic appliances with polycarbonate brackets because non-polycarbonate 
brackets may not be implicated in this phenomenon. Therefore from the wide array of orthodontic polymers 
only one class of materials could be considered as a verified source of concern.  
It should be also noted that even if the case of definitive BPA release the levels are within the range 
found in humans exposed to this agent through dietary habits (canned food), and therefore, although there 
should be an effort to eliminate all additional sources of BPA release, the amounts of BPA released may not 
pose a threat for the average patient. Because of lack of evidence however, pregnant patients, and most 
importantly orthodontists and team who come in contact with grinding products in the form of aerosol 
during debonding are advised to take extra safety measures, as noted previously. 
Caution should be applied in designing effective measures to minimize exposure to patients and staff. 
Special consideration must be given to the specific conditions of orthodontic practice. Thus, adoption of 
general guidelines which were intended for professionals in materials industries or other groups of workers 
by Orthodontists may have futile result and is of unsubstantiated validity. To this end, setting a minimum 
exposure contact concentration per time interval, i.e., X micrograms per day, for BPA-containing orthodontic 
materials is a confusing and profoundly unsubstantiated proposal because of the following:  
a) There is no direct contact with BOA-containing materials anyway; 
b) The proposal is apparently directed to the staff of the practice, with unpredictable impact on the 
perception of the hazard by patients; and 
c) Even if direct contact with resins containing BPA materials took place, the precise estimation of the 
BPA exposure is impossible because the concentration of BOA in the material is unknown.  
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 Absolute measures of eliminating exposure 
Certain ways to prevent patients and most importantly operator and staff from being exposed to BPA 
include absolute measures to ensure lack of contact of patients and operators with BPA and relative 
measures to effectively minimize the exposure to this agent. The proposal of these measures take into 
account the evidence published until June 2017, when about two dozens of studies connecting orthodontic 
materials with BPA were accessible. Therefore, the evidence cannot be considered as a golden rule as it 
possesses a validity which might have definitive duration. In as much, whereas the propositions appended 
below are based on evidence derived primarily from in vivo studies, no comparative data is available on the 
effect of choosing one over the other (i.e., absolute vs. relative measures) as a strategy to minimize 
exposure of the involved parties in an orthodontic setting.  
Materials  
The first category (effective elimination of BPA exposure) includes bonding with glass-ionomer cements 
(not resin-modified glass ionomers), use of metallic or ceramic aesthetic brackets, and Hawley type of 
retainers. Elastomeric modules are mainly polyurethane-based polymers and possess no known risk of 
leaching BPA, while for many other categories of polymers such as polypropylene protective sleeves, Teflon- 
or polyamide-covered wires, a conclusive evidence is lacking. 
The second category (relative measures), includes the use of non-BPA derived orthodontic 
adhesives, mainly non-benzoic ring-containing monomers, to eliminate the case of releasing BPA, or 
adhesives where BPA is not used as a precursor for the manufacturing of the monomer. Although this is 
difficult to identify for the public or the trained professionals, it seems not to be of critical importance since a 
clinical study showed that by having the patients rinse thoroughly after bonding, the levels of BPA in their 
saliva or rinsing medium returned to the baseline levels.46 Contrary to previously anecdotal propositions to 
utilize ethanol solutions in order to induce accelerated ageing thereby increasing the release and somehow 
inducing a ‘BPA drain’ of the polymer, this in vivo assessment revealed that this remedy had no effect. The 
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fact that most literature identifies the first time period after bonding as the time span with the highest 
release, implies that bonding is a critical step in controlling potential release. Multiple rinsing after bonding 
and a suggestion to continue this for some hours may return the initially higher salivary BPA content to 
baseline levels.  
Along the same line, use ceramic brackets, or polyoxymethylene plastic brackets until the evidence 
becomes more conclusive on the actual in vivo release of BPA from polycarbonate brackets, is suggested. 
Processes (bonding and debonding) 
Having established that apart from materials, certain procedures such as thorough rinsing may aid in 
decreasing exposure to BPA during bonding, it is interesting to identify some factors, which may affect 
exposure to BPA during debonding. 
For debonding, removal as much materials as possible without the use of rotary instruments is 
suggested. This can be modulated by selecting a bracket mesh and adhesive combination where the 
application of stresses during debonding would result in a composite cohesive/bracket-resin adhesive type 
of fracture.47 In general, optimum mesh grade for increased debonding results in reinforcement of the 
bracket-adhesive interface shifting the fracture type to the enamel-adhesive complex, thus resulting in 
leaving a large layer of remnant adhesive onto the enamel, which in turn necessitates longer and more 
laborious removal process.  Remnant adhesive volume is also influenced by the modulus of the adhesive, 
however the multiplicity of combinations may prevent from providing a clear suggestion, prompting for an 
empirical selection of the combination which maintain integrity of the bond, while allowing for efficient 
cleaning and resin grinding stage. In addition, the staff and operator should take extra care with mask, fresh 
air access, surgical suction to minimize spread of the aerosol in the operatory. This aerosol apart from having 
estrogenic action as demonstrated in a clinical simulation of the debonding process in vitro, is composed of 




Therefore, debonding may be facilitated by the use of adhesive removing pliers, with limited use of 
rotary instruments coupled with measures to avoid dispersion of the aerosol in the operatory. It is worth 
noting that operatories with multiple dental units within the same area (open bay plan) must allow for 
sufficient space between chairs and avoid scheduling concurrent debonding appointments in multiple chairs 
to minimize the production of aerosol. 
 
RESPONSE TO PUBLIC QUERIES 
Some years after the saga of amalgam, the dental practitioner is faced again with queries, often 
aggressive, posed by internet-educated and ill-informed patients and parents on BPA release from dental 
and more specifically from orthodontic materials. Dealing with these challenges necessitates not only an 
overview of the issue to the point of understanding doctoral level biological and materials research, but also 
knowledge of the relevant legislature statutes, which may vary considerably among countries; this is a 
daunting task, and it is practically impossible for the practicing orthodontist. The objective of this section is 
to provide the interested clinicians and organizations with the minimum required background in order to 
efficiently address questions relating to BPA In everyday orthodontic practice. For this purpose the Table 
provided may be useful to reassure all interested parties that measures taken to eliminate exposure to BPA, 
include a wide spectrum of means, as noted in the previous section, which effectively limit the exposure to 
levels below the dietary intake of an average person. 
As an introductory remark it might be worth noting that the extent of detrimental effects of BPA 
described in the relevant literature relate mostly to specific age ranges of animals and humans, which 
correspond to foetuses, and not to adolescents or developed organisms. Therefore, although exposure to 
BPA is unwanted, care should be taken to selectively focus in cases where developmental effects can be 
produced and that means pregnant patients or clinical/staff members.  
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To this end, it is interesting to consider that the exposure of patients to BPA is much lower than that 
of the operator and staff who participate in many bonding/debonding procedures daily. Thus, although 
emphasis should be placed in protecting patients from exposure to BPA, this population should not be the 
main target of measures aiming at reducing the exposure to BPA. 
Going into the analysis of published evidence, it must be emphasized that the literature can be 
viewed differently depending on the level of expertise of the reader, and therefore, a clinical professional or 
lay person, without proper background, cannot assess the validity and limitations of experimental 
procedures and technicalities of testing. The majority of the evidence available on the topic derives mainly 
from in vitro experimental approaches using plethora of variables, conditions, ageing/immersion media, and 
with analytical techniques of variable thresholds and therefore wide range of sensitivity. The levels of BPA 
associated with orthodontic materials and procedures such as bonding and debonding vary significantly 
among studies and in general exceed some of the values reported in the literature to induce effects in 
animals.  
However, this evidence has been derived from studies, which were performed under specific 
conditions, irrelevant to the actual clinical situation. For example the study of release of BPA from 
orthodontic adhesives, which involves immersing the adhesive in media immediately after photocuring, or 
investigating the salivary levels of BPA after bonding orthodontic adhesives or sealants, results in a technical 
increase of the release of unpolymerized species from the material. This is because unpolymerized layers are 
allowed to leach compounds in the media, where in reality the patient rinses away whatever would later be 
released in the media as part of the bonding protocol, which should include thorough rinsing after each time 
a sealant or composite filling material or orthodontic adhesive for bracket or lingual fixed retainer bonding is 
placed in the oral cavity. Therefore, the result of laborious and technically demanding analyses simply test a 
condition, which is not taking place in everyday practice. 
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Supporting evidence on the implication of the conditions of sample collection during bonding in the 
outcome of BPA release of adhesive is also provided by a recent study, indicating that the levels of BPA, 
which in this study were much higher than those reported in other publications, returned to baseline or pre-
bonding levels, after rinsing with water.46 This again implies that part of the release relates to the 
unpolymerized layer of material, which is removed after bonding. A second rinse in this investigation showed 
BPA levels within the range of those found before bonding. The significance of this finding is two-fold: it 
provides a first line of means to eliminate BPA release and also suggests that much of the in vitro analyses 
and complicated attempts to simulate the clinical situation are invalid, prompting, once more, for the design 
of clinical studies to obtain meaningful and clinically relevant data. 
Collectively, a critical analysis of the evidence available on the BPA release from orthodontic 
materials, suggests that it is not only the selection of materials that modulates the release of BPA, rather, 
the adherence to proper treatment protocols during these stages of treatment can effectively minimize 
exposure of patients and personnel to this chemical to the levels below what is established as standard 












Sources of BPA release and effects in Orthodontics and suggested measures to minimize exposure for the 






MANAGEMENT OF EXPOSURE 
& SUGGESTED MEASURES 
Target group of 
interest 
 BONDING 













Resin-based adhesives as lingual 
















  Use glass-ionomer cements 
 
Request details on BPA use at any stage 
of production by the manufacturer 
 
Optimize polymerization conditions 
(sufficient light exposure times, close 
proximity of tip to bracket and adequate 
light intensity) 
 
Have the patient rinse with copious 
amount of water following bonding 
 
 
Sufficient adhesive hardness is essential 
owing to the exposure of the adhesive to 
masticatory forces 
 
Request details on BPA use at any stage 
of production by the manufacturer 
 
Ceramic brackets as aesthetic appliances 
 
  
Inconclusive evidence at this stage 
 
Select a bracket base mesh-adhesive filler 
content combination, which results in a 
resin cohesive/bracket-adhesive fracture 
 
Remove as much material as possible 
without the use of rotary instruments 
 
During resin grinding have access to fresh 
air, use surgical suction, masks for all staff  
 
Pregnant staff and operators must avoid 
continuous and long-term exposure to the 

































Operatories with multiple dental units 
within the same area (open bay plan) 
must allow for sufficient space between 
chairs and avoid scheduling concurrent 
debonding appointments in multiple 
chairs   
 
 
 Table is provided as a demonstration of representative evidence per category of BPA source. It is not 
supposed to exhaustively cover all published studies on the topic, neither does it endorse a priori the 
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